Warren RB, Lebwohl M, Thaci D, Gooderham M, et al. Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque psoriasis: Long-term results from the BE RADIANT phase 3b trial open-label extension period. Br J Dermatol 2025 Jan 25:ljaf032. doi: 10.1093.
PMID: 39862230